With proper patient selection, expectant, medical, and surgical treatments are 82%, 90%, and 92% successful, respectively.[85]Trio D, Strobelt N, Picciolo C, et al. Prognostic factors for successful expectant management of ectopic pregnancy. Fertil Steril. 1995 Mar;63(3):469-72.
http://www.ncbi.nlm.nih.gov/pubmed/7851572?tool=bestpractice.com
[86]Shalev E, Peleg D, Tsabari A, et al. Spontaneous resolution of ectopic tubal pregnancy: natural history. Fertil Steril. 1995 Jan;63(1):15-9.
http://www.ncbi.nlm.nih.gov/pubmed/7805905?tool=bestpractice.com
[87]Lipscomb GH, McCord ML, Stovall TG, et al. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med. 1999 Dec 23;341(26):1974-8.
http://www.nejm.org/doi/full/10.1056/NEJM199912233412604#t=article
http://www.ncbi.nlm.nih.gov/pubmed/10607814?tool=bestpractice.com
The rate of recurrent ectopic pregnancy is 5% to 20%, but it rises to >30% in women with two consecutive ectopic pregnancies.[88]Tenore JL. Ectopic pregnancy. Am Fam Physician. 2000 Feb 15;61(4):1080-8.
https://www.aafp.org/afp/2000/0215/p1080.html
http://www.ncbi.nlm.nih.gov/pubmed/10706160?tool=bestpractice.com
[89]Tay JI, Moore J, Walker JJ. Ectopic pregnancy. BMJ. 2000 Apr 1;320(7239):916-9.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1117838
http://www.ncbi.nlm.nih.gov/pubmed/10742003?tool=bestpractice.com
The future fertility and tubal patency rates in laparoscopically treated women are similar to those in the medically managed group.[47]ACOG practice bulletin no. 193: tubal ectopic pregnancy. Obstet Gynecol. 2018 Mar;131(3):e91-103.
http://www.ncbi.nlm.nih.gov/pubmed/29470343?tool=bestpractice.com
[57]Hendriks E, Rosenberg R, Prine L. Ectopic pregnancy: diagnosis and management. Am Fam Physician. 2020 May 15;101(10):599-606.
https://www.aafp.org/afp/2020/0515/p599.html
http://www.ncbi.nlm.nih.gov/pubmed/32412215?tool=bestpractice.com
[90]Desroque D, Capmas P, Legendre G, et al. Fertility after ectopic pregnancy [in French]. J Gynecol Obstet Biol Reprod (Paris). 2010 Sep;39(5):395-400.
http://www.ncbi.nlm.nih.gov/pubmed/20478667?tool=bestpractice.com
[91]Fernandez H, Capmas P, Lucot JP, et al. Fertility after ectopic pregnancy: the DEMETER randomized trial. Hum Reprod. 2013 May;28(5):1247-53.
http://humrep.oxfordjournals.org/content/28/5/1247.long
http://www.ncbi.nlm.nih.gov/pubmed/23482340?tool=bestpractice.com
In women with a normal contralateral tube, salpingostomy does not appear to improve fertility prospects compared with salpingectomy.[71]Po L, Thomas J, Mills K, et al. Guideline no. 414: management of pregnancy of unknown location and tubal and nontubal ectopic pregnancies. J Obstet Gynaecol Can. 2021 May;43(5):614-30.e1.
http://www.ncbi.nlm.nih.gov/pubmed/33453378?tool=bestpractice.com
[82]Mol F, van Mello NM, Strandell A, et al. Salpingotomy versus salpingectomy in women with tubal pregnancy (ESEP study): an open-label, multicentre, randomised controlled
trial. Lancet. 2014 Apr 26;383(9927):1483-9.
http://www.ncbi.nlm.nih.gov/pubmed/24499812?tool=bestpractice.com
[92]Cheng X, Tian X, Yan Z, et al. Comparison of the fertility outcome of salpingotomy and salpingectomy in women with tubal pregnancy: a systematic review and meta-analysis. PLoS One. 2016 Mar 25;11(3):e0152343.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807767
http://www.ncbi.nlm.nih.gov/pubmed/27015601?tool=bestpractice.com
Neither methotrexate nor salpingectomy affect subsequent ovarian response and pregnancy with IVF in women treated for ectopic pregnancy resulting from IVF.[93]Wiser A, Gilbert A, Nahum R, et al. Effects of treatment of ectopic pregnancy with methotrexate or salpingectomy in the subsequent IVF cycle. Reprod Biomed Online. 2013 May;26(5):449-53.
http://www.rbmojournal.com/article/S1472-6483(13)00064-3/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/23518030?tool=bestpractice.com
[94]Boots CE, Hill MJ, Feinberg EC, et al. Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes. J Assist Reprod Genet. 2016 May;33(5):647-56.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870444
http://www.ncbi.nlm.nih.gov/pubmed/26943917?tool=bestpractice.com
[95]Yoon SH, Lee JY, Kim SN, et al. Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles? Fertil Steril. 2016 Oct;106(5):1083-92.e5.
https://www.fertstert.org/article/S0015-0282(16)61300-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/27336211?tool=bestpractice.com